Rocket Lab’s record quarter supports growth despite Neutron delays
Rocket Lab posted record Q2 revenue, backlog, and gross margin, reinforcing confidence despite market focus on Neutron launch timing. Neutron is framed as critical for future upside, including a $397 million satellite contract and access to expanded NSSL opportunities. Cash burn and potential dilution remain key watchpoints until Neutron debuts.
Coverage (3)
- Rocket Lab Corporation (NASDAQ:RKLB) Receives Average Recommendation of "Moderate Buy" from Brokerages (marketbeat.com)
- Rocket Lab Doesn't Need Neutron To Justify This Quarter, But Does For What's Next (RKLB) (seekingalpha.com)
- Rocket Lab Doesn't Need Neutron To Justify This Quarter, But Does For What's Next (RKLB) (seekingalpha.com)